Regeneron Completes Acquisition Of Decibel Therapeutics, Adding Promising Gene Therapy Programs For Hearing Loss
Acquiring Company
Regeneron
Acquired Company
Decibel Therapeutics, Inc.
TarrytownMassachusettsBiotechnologyHealth CareScience And EngineeringTherapeuticsBiotechnologyHealth CareTherapeuticsDescription
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has successfully completed its acquisition of Decibel Therapeutics, Inc., strengthening the company’s gene therapy and auditory programs.
Quick answer
Regeneron is acquiring Decibel Therapeutics, Inc., announced September 25, 2023. Regeneron is based in Tarrytown, New York, United States.
- Who acquired Decibel Therapeutics, Inc?
- Regeneron agreed to acquire Decibel Therapeutics, Inc. on September 25, 2023.
- How much did Regeneron pay for Decibel Therapeutics, Inc?
- The deal value was not disclosed.
- What does Regeneron do?
- Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases.
- Where are Regeneron and Decibel Therapeutics, Inc. based?
- Regeneron is based in Tarrytown, New York, United States. Decibel Therapeutics, Inc. is based in Massachusetts, United States.
Source: Fundz verified event record.
Other recent acquisitions in Science And Engineering and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Scilex Holding Company Announces The Consummation Of The Previously Announced Purchase Of All Of The Scilex Common Shares, Preferred Shares And Warrants Owned By Sorrento Therapeutics, Inc. (September 21, 2023)
- United Therapeutics To Acquire Miromatrix Medical (October 30, 2023)
- Emmes Acquires Vaxtrials (October 5, 2023)
- Lilly To Acquire Point Biopharma To Expand Oncology Capabilities Into Next-Generation Radioligand Therapies (October 3, 2023)
- Abbott Completes Acquisition Of Bigfoot Biomedical (September 22, 2023)
- Abbott To Acquire Bigfoot Biomedical, Furthering Efforts To Develop Personalized, Connected Solutions For People With Diabetes (September 5, 2023)
Who to call at Regeneron, and when
When Regeneron changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Regeneron raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Regeneron, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Regeneron. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Regeneron makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Decibel Therapeutics, Inc.?
Decibel Therapeutics, Inc. was acquired by Regeneron, based in Tarrytown. The deal was reported on September 25, 2023. Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Regeneron is publicly traded (REGN) and operates in Biotechnology.
When did Regeneron acquire Decibel Therapeutics, Inc.?
Regeneron's acquisition of Decibel Therapeutics, Inc. was reported on September 25, 2023. Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has successfully completed its acquisition of Decibel Therapeutics, Inc., strengthening the company’s gene therapy and auditory programs. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Decibel Therapeutics, Inc. do?
Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair and restore hearing. It is privately held, operating in Biotechnology, and is based in Massachusetts.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.